Abstract
Although some anti-allergic activities of the rhizome of Atractylodes japonica have been previously reported, the active principle(s) for anti-allergic action is not fully elucidated and the effect of this plant material on atopic dermatitis (AD) is not known. In this study, the 70% ethanol extract of the rhizome of A. japonica was found to significantly inhibit 5-lipoxygenase (5-LOX)-catalyzed leukotrienes (LT) production from rat basophilic leukemia (RBL)-1 cells. From the extract of A. japonica, three major sesquiterpene derivatives including atractylenolide I, atractylenolide III and eudesma-4,7-dien-8-one were successfully isolated. Among these compounds, only atractylenolide I was shown to strongly inhibit 5-LOX from RBL-1 cells (IC50 = 18.6 μM). To evaluate the effects of experimental AD, the ethanol extract of A. japonica (200 mg/day) was administered orally to hapten-treated NC/Nga mice which is an animal model of AD. It was firstly found that the extract significantly inhibited AD-like symptoms in mice, as judged by severity score and scratching behavior. Taken together, it is concluded that A. japonica possesses the inhibitory activity on 5-LOX and an animal model of AD, and atractylenolide I may contribute, at least in part, to these anti-allergic actions of A. japonica.
References
Chang, Y.-H., Kim, C., Jung, M., Lim, Y.-H., Lee, S., and Kang, S., Inhibition of melanogenesis by selina-4(14),7(11)-dien-8-one isolated from Atractylodis Rhizoma Alba. Biol. Pharm. Bull., 30, 719–723 (2007).
Choi, K. H., Jeong, S. I., Lee, J. H., Hwang, B. S., Kim, S. J., Lee, S., Choi, B. K., and Jung, K. Y., Pharmacological mechanism responsible for the Atractylodes japonica-induced distal colonic contraction in rats. Phytomedicine, 18, 408–413 (2011a).
Choi, K. H., Jeong, S. I., Lee, J. H., Hwang, B. S., Lee, S., Choi, B. K., and Jung, K. Y., Acetylene compound isolated from Atractylodes japonica stimulates the contractility of rat distal colon via inhibiting the nitrergic-purinergic relaxation. J. Ethnopharmacol., 134, 104–110 (2011b).
Choi, O. H., Kim, J. H., and Kinet, J. P., Calcium mobilization via sphingosine kinase in signaling by the FcɛRI antigen receptor. Nature, 380, 634–636 (1996).
Ding, H.-Y., Wu, Y.-C., and Lin, H.-C., Phytochemical and pharmacological studies on Chinese changzhu. J. Chin. Chem. Soc., 47, 561–566 (2000).
Dong, H., He, L., Huang, M., and Dong, Y., Anti-inflammatory compounds isolated from Atractylodes macrocephala Koidz. Nat. Prod. Res., 22, 1418–1427 (2008).
Duan, J., Wang, L., Qian, S., Su, S., and Tang, Y., A new cytotoxic prenylated dihydrobenzofuran derivative and other chemical constituents from the rhizomes of Atractylodes lancea DC. Arch. Pharm. Res., 31, 965–969 (2008).
Han, S. B., Lee, C. W., Yoon, Y. D., Lee, J. H., Kang, J. S., Lee, K. H., Yoon, W. K., Lee, K., Park, S. K., and Kim, H. M., Prevention of arthritic inflammation using an oriental herbal combination BDX-1 isolated from Achyranthes bidentata and Atractylodes japonica. Arch. Pharm. Res., 28, 902–908 (2005).
Hong, M. H., Kim, J.-H., Bae, H., Lee, N.-Y., Shin, Y.-C., Kim, S.-H., and Ko, S.-G., Atractylodes japonica Koidzumi inhibits the production of pro-inflammatory cytokines through inhibition of the NF-κB/IκB signal pathway in HMC-1 human mast cells. Arch. Pharm. Res., 33, 843–851 (2010).
Jang, M. H., Shin, M. C., Kim, Y. J., Kim, C. J., Kim., Y., and Kim, E. H., Atractylodes japonica suppresses lipopolysaccharide-stimulated expressions of inducible nitric oxide synthase and cyclooxygenase-2 in RAW 264.7 macrophages. Biol. Pharm. Bull., 27, 324–327 (2004).
Jeong, S.-I., Kim, S.-Y., Kim, S.-J., Hwang, B.-S., Kwon, T.-H., Yu, K.-Y., Hang, S.-H., Suzuki, K., and Kim, K.-J., Antibacterial activity of phytochemicals isolated from Atractylodes japonica against methicillin-resistant Staphylococcus aureus. Molecules, 15, 7395–7402 (2010).
Kang, T. H., Han, N. R., Kim, H. M., and Jeong, H. J., Blockade of IL-6 secretion pathway by the sesquiterpenoid atractylenolide III. J. Nat. Prod., 74, 223–227 (2011).
Kitajima, J., Kamoshita, A., Ishikawa, T., Takano, A., Fukuda, T., Isoda, S., and Ida, Y., Glycosides of Atractylodes japonica. Chem. Pharm. Bull., 51, 152–157 (2003).
Leung, D. Y. M., Hirsch, R. L., Schneider, L., Moody, C., Takaoka R., Li, S. H., Meyerson, L. A., Mariam, S. G., Goldstein, G., and Hanifin, J. M., Thymopentin therapy reduces the clinical severity of atopic dermatitis. J. Allergy Clin. Immunol., 85, 927–933 (1990).
Leung, D. Y. M., Atopic dermatitis: The skin as a window into the pathogenesis of chronic allergic diseases. J. Allergy Clin. Immunol., 96, 302–319 (1995).
Li, C. Q., He, L. C., Dong, H. Y., and Jin, J. Q., Screening for the anti-inflammatory activity of fractions and compounds from Atractylodes macrocephala Koidz. J. Ethnopharmacol., 114, 212–217 (2007a).
Li, C. Q., He, L. C., and Jin, J. Q., Atractylenolide I and atractylenolide III inhibit lipopolysaccharide-induced TNF-α and NO production in macrophages. Phytother. Res., 21, 347–353 (2007b).
Marquardt, D. L. and Wasserman, S. I., Modulation of rat serosal mast cell biochemistry by in vivo dexamethasone administration. J. Immunol., 131, 934–939 (1983).
Matsuda, H., Watanabe, N., Geba, G. P., Sperl, J., Tsudzuki, M., and Hiroi, J., Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int. Immunol., 9, 461–468 (1997).
Mossman, T., Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assays. J. Immunol. Methods, 65, 55–63 (1983).
Murota, H. and Katayama, I., Assessment of antihistamines in the treatment of skin allergies. Curr. Opin. Allergy Clin. Immunol., 11, 428–437 (2011).
Novak, N., New insights into the mechanism and management of allergic disease: atopic dermatitis. Allergy, 64, 265–275 (2009).
Oyoshi, M. K., He, R., Kumar, L., Yoon, J., and Geha, R. S., Cellular and molecular mechanisms in atopic dermatitis. Adv. Immunol., 102, 135–226 (2009).
Park, H. Y., Lim, H., Kim, H. P., and Kwon, Y. S., Downregulation of matrix metalloproteinase-13 by the root extract of Cyathula officinalis Kuan and its constituents in IL-1β-treated chondrocytes. Planta Med., 77, 1528–1530 (2011).
Pu, S., Pu, H., Jin, D., Qu, X., Zhang, T., Jiang, G., Bai, Y., and Jin, H., Effect of n-butanol extract of Japanese atractylodes (Atractylodes japonica) on gastric ulcer in rats. Zhongcaoyao, 27, 410–413 (1996).
Rubin, P. and Mollison, K. W., Pharmacotherapy of diseases mediated by 5-lipoxygenase pathway eicosanoids. Prostaglandins Other Lipid Mediat., 83, 188–197 (2007).
Rudikoff, D. and Lebwohl, M., Atopic dermatitis. Lancet, 351, 1715–1721 (1998).
Schwartz, L. B., Lewis, R. A., Seldin, D., and Austen, F., Acid hydrolases and tryptase from secretory granules of disrupted human lining mast cells. J. Immunol., 126, 1290–1294 (1981).
Suto, H., Matsuda, H., and Mitsuishi, K., NC/Nga mice: a mouse model for atopic dermatitis. Int. Arch. Allergy Immunol., 120, 70–75 (1999).
Suzuki, R., Shimizu, T., Kudo, T., Yamashiro, Y., and Oshida, K., Effects of n-3 polyunsaturated fatty acids on dermatitis in NC/Nga mice. Prostaglandins Leukot. Essent. Fatty Acids, 66, 435–440 (2002).
Tries, S., Neupert, W., and Laufer, S., The mechanism of action of the new anti-inflammatory compound ML3000: inhibition of 5-LOX and COX-1/2. Inflamm. Res., 51, 135–143 (2002).
Yamamoto, K., Yamashita, K., Hitomi, N., Suzuki, A., and Yoneda, K., Studies on the constituents of atractylodes rhizome, constituents in the rhizome of Atractylodes japonica and TLC analysis of Jutsu. Shoyakugaku Zasshi, 47, 12–16 (1993).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lim, H., Lee, J.H., Kim, J. et al. Effects of the rhizomes of Atractylodes japonica and atractylenolide I on allergic response and experimental atopic dermatitis. Arch. Pharm. Res. 35, 2007–2012 (2012). https://doi.org/10.1007/s12272-012-1118-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-012-1118-3